AURKA against 1
Compound Ac13 (AURKA inhibitor 1) is a potent and selective Aurora kinase A (AURKA) inhibitor with sub-nanomolar IC50. It suppresses tumor cell proliferation by targeting the acetylation of endogenous lysine K162, a modification reversibly regulated by SIRT3 in cellular models like HCT116. This inhibitor is a valuable tool for studying AURKA signaling in cancer research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin, Signal Transduction
Molecular Formula
C28H32FN9O2
Molecular Weight
545.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15085303 1 Vial
Lentiviral human DOCK8 shRNA (UAS) - Lentiviral human DOCK8 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
041199-ML405 100 µL
RPL22, CT (RPL22, 60S ribosomal protein L22, EBER-associated protein, Epstein-Barr virus small RNA-associated protein, Heparin-binding protein HBp15) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
